HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

European guidelines for cervical cancer screening now recommend the use of clinically validated assays for high-risk HPV-DNA sequences as primary test in women older than 30  years, performed in centralized lab...

Source: BMC Women's Health - March 25, 2019 Category: OBGYN Authors: Helena Frayle, Silvia Gori, Martina Rizzi, Bianca Nives Graziani, Elisa Vian, Paolo Giorgi Rossi and Annarosa Del Mistro Tags: Technical advance Source Type: research